New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
10:31 EDTLINE, EVEP, ABB, LNCO, FNP, CCJ, CYTX, DOX, SYMC, MEMP, NSR, NUAN, HPTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Cytori Therapeutics (CYTX) initiated with a Buy at Ascendiant Capital... Hospitality Properties (HPT) initiated with a Market Perform at JMP Securities... Memorial Production (MEMP) initiated with a Buy at Wunderlich... Roadrunner (RRTS) initiated with a Buy at Deutsche Bank... Cameco (CCJ) initiated with a Buy at Cantor... Symantec (SYMC) initiated with a Buy at B. Riley Caris... Nuance (NUAN) initiated with a Neutral at B. Riley Caris... NeuStar (NSR) initiated with a Neutral at B. Riley Caris... Fifth & Pacific (FNP) initiated with a Buy at BB&T... Amdocs (DOX) initiated with a Neutral at B. Riley Caris... EV Energy (EVEP) initiated with an Overweight at JPMorgan... LinnCo (LNCO) initiated with an Overweight at JPMorgan... LINN Energy (LINE) initiated with an Overweight at JPMorgan... ABB (ABB) initiated with an Outperform at Credit Suisse.
News For CYTX;HPT;MEMP;CCJ;NUAN;SYMC;FNP;NSR;DOX;LNCO;EVEP;LINE;ABB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 18, 2015
06:51 EDTLNCOLinnCo downgraded to Sell from Neutral at Goldman
Subscribe for More Information
06:51 EDTLINELINN Energy downgraded to Sell from Neutral at Goldman
Subscribe for More Information
06:05 EDTDOXAmdocs data management services selected by Telefonica
Subscribe for More Information
May 15, 2015
16:51 EDTDOXGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
07:26 EDTSYMCSymantec outlook still positive despite earnings miss, says JMP Securities
After Symantec reported lower than expected Q4 EPS, JMP Securities says that after adjusting for foreign currency fluctuations and a true-up of defined-benefit plans, the EPS would have beat expectations by 1c. The firm says the company's headline Q1 EPS guidance also missed expectations but would have beaten after adjusting for currency and an extra selling week in last year's Q1. The firm thinks that the company's profitability is improving ,and it keeps a $30 price target and Outperform rating on the shares.
07:13 EDTDOXAmdocs deal can be up to 30c accretive to EPS, says Stifel
After Amdocs (DOX) agreed to buy Comverse's (CNSI) BSS business for $272M in cash, Stifel says the deal should increase Amdocs' combined operating margins by 50 basis points to 100 basis points, leading to accretion of approximately 15c-30c. The firm keeps a $60 price target and Buy rating on Amdocs.
May 14, 2015
19:02 EDTSYMCOn The Fly: After Hours Movers
Subscribe for More Information
17:27 EDTSYMCSymantec 'on track' to separate Veritas as stand alone company on Jan. 2, 2016
Subscribe for More Information
16:04 EDTSYMCSymantec sees Q1 adjusted operating margin 27%-28%
Subscribe for More Information
16:03 EDTSYMCSymantec sees FY16 EPS $1.80-$1.90, consensus $1.90
Subscribe for More Information
16:02 EDTSYMCSymantec sees Q1 EPS 41c-44c, consensus 45c
Sees Q1 revenue $1.5B-$1.54B, consensus $1.62B
16:01 EDTSYMCSymantec reports Q4 adjusted EPS 43c, consensus 44c
Subscribe for More Information
15:08 EDTSYMCSymantec May volatility elevated on wide price movement
Subscribe for More Information
15:01 EDTSYMCNotable companies reporting after market close
Subscribe for More Information
08:21 EDTSYMCFinjan says patent suits ongoing with numerous cybersecurity companies
Finjan (FNJN) said it has an active Markman Hearing schedule with two Markman Hearings already concluded in favor of the company and two additional Markman Hearings to be held in Q2. The company has a two-week trial against Blue Coat set to commence on July 20. Finjan has patent infringement lawsuits against FireEye (FEYE), BlueCoat, Proofpoint (PFPT), Sophos, Symantec (SYMC), and Palo Alto Networks (PANW) relating to, collectively, more than 20 patents in the Finjan portfolio. Subsequent to the quarter end, Finjan entered into a negotiated license agreement with F-Secure Corporation, a company incorporated in Finland. The agreement provides for F-Secure to pay Finjan the sum of $1M in cash, to be paid in two installments, consisting of $700,000 which was received on April 22 and $300,000 on or before March 31, 2016. The agreement also provides for the assignment by F-Secure to Finjan of two patents, U.S. Patent Nos. 8,474,048 and 7,749,991.
May 12, 2015
06:43 EDTCYTXCytori Therapeutics coverage assumed with a Buy at Ascendiant
Subscribe for More Information
May 11, 2015
16:29 EDTCYTXCytori Therapeutics reports Q1 EPS ex-charge (7c), consensus 7c
Reports Q1 revenue $902,000, consensus $2.44M. Reports cash and debt balances at March 31 of approximately $13.2M.
12:11 EDTNUANNuance downgraded to Hold from Buy at Standpoint Research
Subscribe for More Information
09:21 EDTEVEPOn The Fly: Pre-market Movers
Subscribe for More Information
06:20 EDTEVEPEV Energy reports Q1 EPS ($1.25), may not compare to consensus 17c
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use